These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 21744037

  • 1. Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.
    Debourgogne A, de Hoog S, Lozniewski A, Machouart M.
    Eur J Clin Microbiol Infect Dis; 2012 Apr; 31(4):615-8. PubMed ID: 21744037
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.
    Al-Hatmi AM, Normand AC, Ranque S, Piarroux R, de Hoog GS, Meletiadis J, Meis JF.
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795379
    [Abstract] [Full Text] [Related]

  • 4. In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
    Venturini TP, Rossato L, Spader TB, Tronco-Alves GR, Azevedo MI, Weiler CB, Santurio JM, Alves SH.
    Diagn Microbiol Infect Dis; 2011 Oct; 71(2):126-30. PubMed ID: 21840673
    [Abstract] [Full Text] [Related]

  • 5. Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
    Mukherjee PK, Chandra J, Yu C, Sun Y, Pearlman E, Ghannoum MA.
    Invest Ophthalmol Vis Sci; 2012 Jul 03; 53(8):4450-7. PubMed ID: 22669723
    [Abstract] [Full Text] [Related]

  • 6. Epidemiological aspects and characterization of the resistance profile of Fusarium spp. in patients with invasive fusariosis.
    Rosa PDD, Ramirez-Castrillon M, Borges R, Aquino V, Meneghello Fuentefria A, Zubaran Goldani L.
    J Med Microbiol; 2019 Oct 03; 68(10):1489-1496. PubMed ID: 31419209
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J, Peláez T, Alcalá L, Bouza E.
    Diagn Microbiol Infect Dis; 2006 Sep 03; 56(1):53-5. PubMed ID: 16650953
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC, Hsieh MI, Choi PC, Wu CJ.
    J Clin Microbiol; 2018 Oct 03; 56(10):. PubMed ID: 30093391
    [Abstract] [Full Text] [Related]

  • 11. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L.
    Antimicrob Agents Chemother; 2005 Aug 03; 49(8):3572-4. PubMed ID: 16048988
    [Abstract] [Full Text] [Related]

  • 12. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.
    Al-Hatmi AM, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, Meis JF.
    J Antimicrob Chemother; 2015 Apr 03; 70(4):1068-71. PubMed ID: 25538167
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
    Badali H, Cañete-Gibas C, Patterson H, Sanders C, Mermella B, Garcia V, Mele J, Fan H, Wiederhold NP.
    Mycoses; 2021 Jul 03; 64(7):748-752. PubMed ID: 33755988
    [Abstract] [Full Text] [Related]

  • 14. In Vitro Activity of Chlorhexidine Compared with Seven Antifungal Agents against 98 Fusarium Isolates Recovered from Fungal Keratitis Patients.
    Oliveira Dos Santos C, Kolwijck E, van der Lee HA, Tehupeiory-Kooreman MC, Al-Hatmi AMS, Matayan E, Burton MJ, Eggink CA, Verweij PE.
    Antimicrob Agents Chemother; 2019 Aug 03; 63(8):. PubMed ID: 31182529
    [Abstract] [Full Text] [Related]

  • 15. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J, Peláez T, Alcalá L, Bouza E.
    Diagn Microbiol Infect Dis; 2007 Mar 03; 57(3):273-6. PubMed ID: 17141455
    [Abstract] [Full Text] [Related]

  • 16. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA, Messer SA, Hollis RJ, Jones RN, SENTRY Participants Group.
    Antimicrob Agents Chemother; 2002 Apr 03; 46(4):1032-7. PubMed ID: 11897586
    [Abstract] [Full Text] [Related]

  • 17. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Lewis RE, Wiederhold NP, Klepser ME.
    Antimicrob Agents Chemother; 2005 Mar 03; 49(3):945-51. PubMed ID: 15728887
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates.
    Minassian B, Huczko E, Washo T, Bonner D, Fung-Tomc J.
    Clin Microbiol Infect; 2003 Dec 03; 9(12):1250-2. PubMed ID: 14686996
    [No Abstract] [Full Text] [Related]

  • 19. Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
    Beernaert LA, Pasmans F, Van Waeyenberghe L, Dorrestein GM, Verstappen F, Vercammen F, Haesebrouck F, Martel A.
    Antimicrob Agents Chemother; 2009 May 03; 53(5):2199-201. PubMed ID: 19258265
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
    Morace G, Drago M, Scaltrito MM, Conti S, Fanti F, Polonelli L, GISIA Participants Group.
    J Chemother; 2007 Oct 03; 19(5):508-13. PubMed ID: 18073149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.